These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35401043)

  • 1. Delayed Graft Function Under the Microscope: Surveillance Biopsies in Kidney Transplantation.
    Castro Filho JBS; Pompeo JC; Machado RB; Gonçalves LFS; Bauer AC; Manfro RC
    Transpl Int; 2022; 35():10344. PubMed ID: 35401043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of delayed graft function duration on function and survival of deceased donor kidney transplants.
    Helfer MS; Pompeo JC; Costa ORS; Vicari AR; Ribeiro AR; Manfro RC
    J Bras Nefrol; 2019; 41(2):231-241. PubMed ID: 30300438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipients.
    Moes DJ; Press RR; Ackaert O; Ploeger BA; Bemelman FJ; Diack C; Wessels JA; van der Straaten T; Danhof M; Sanders JS; Homan van der Heide JJ; Guchelaar HJ; de Fijter JW
    Br J Clin Pharmacol; 2016 Jul; 82(1):227-37. PubMed ID: 27334415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney transplantation from donation after cardiac death: a retrospective cohort study.
    Chen GD; Lai XQ; Ko DS; Qiu J; Wang CX; Han M; Li J; Huang G; He XS; Chen LZ
    Nephrology (Carlton); 2015 Aug; 20(8):539-43. PubMed ID: 25808082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies.
    Haller J; Wehmeier C; Hönger G; Hirt-Minkowski P; Gürke L; Wolff T; Steiger J; Amico P; Dickenmann M; Schaub S
    Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function.
    Ravindra KV; Sanoff S; Vikraman D; Zaaroura A; Nanavati A; Sudan D; Irish W
    Am J Transplant; 2019 Mar; 19(3):781-789. PubMed ID: 30171800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate, Factors, and Outcome of Delayed Graft Function After Kidney Transplantation of Deceased Donors.
    Jahn L; Rüster C; Schlosser M; Winkler Y; Foller S; Grimm MO; Wolf G; Busch M
    Transplant Proc; 2021 Jun; 53(5):1454-1461. PubMed ID: 33612277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 37-year kidney transplantation experience at Siriraj Hospital.
    Premasathian N; Vongwiwatana A; Taweemonkongsap T; Amornvesukit T; Limsrichamrern S; Jitpraphai S; Kositamongkol P; Mahawithitwong P; Sritippayawan S; Chanchairujira T; Nualyong C; Vareesangthip K; Vasuvattakul S; Sirivatanauksorn Y
    Clin Transpl; 2010; ():141-8. PubMed ID: 21696037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility and safety of early allograft biopsy in adult deceased donor kidney transplant recipients.
    Favi E; James A; Puliatti C; Whatling P; Ferraresso M; Rui C; Cacciola R
    Clin Exp Nephrol; 2020 Apr; 24(4):356-368. PubMed ID: 31768863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients.
    Dedinská I; Graňák K; Vnučák M; Skálová P; Laca Ĺ; Krivuš J; Galajda P; Mokáň M
    Transplant Proc; 2019 Dec; 51(10):3259-3264. PubMed ID: 31732198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risk factors, and outcomes of delayed graft function in deceased donor kidney transplantation in a Brazilian center.
    Helfer MS; Vicari AR; Spuldaro F; Gonçalves LF; Manfro RC
    Transplant Proc; 2014; 46(6):1727-9. PubMed ID: 25131022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for and outcomes of delayed graft function in live donor kidney transplantation - a retrospective study.
    Mogulla MR; Bhattacharjya S; Clayton PA
    Transpl Int; 2019 Nov; 32(11):1151-1160. PubMed ID: 31209943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early allograft biopsies performed during delayed graft function may not be necessary under thymoglobulin induction.
    Ortiz J; Parsikia A; Mumtaz K; Khanmoradi K; Balasubramanian M; Feyssa E; Campos S; Zaki R; Chewaproug D
    Exp Clin Transplant; 2012 Jun; 10(3):232-8. PubMed ID: 22631058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and outcomes of prolonged recovery from delayed graft function after deceased kidney transplantation.
    Zhang H; Fu Q; Liu J; Li J; Deng R; Wu C; Nie W; Chen X; Liu L; Wang C
    Ren Fail; 2020 Nov; 42(1):792-798. PubMed ID: 32772773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of clinical outcomes between antithymocyte globulin and basiliximab in renal transplantation from donation after citizen death: a matched pair study].
    Lin KL; Zhu L; Fu C; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):99-103. PubMed ID: 28088952
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors and outcomes of delayed graft function after living-donor kidney transplantation.
    Redfield RR; Scalea JR; Zens TJ; Muth B; Kaufman DB; Djamali A; Astor BC; Mohamed M
    Transpl Int; 2016 Jan; 29(1):81-7. PubMed ID: 26432507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.